EntryPoint Capital’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,786	Closed	-$347K	–	1012
2024 Q1	$347K	Buy	13,786 +4,802	+53%	+$121K	0.31%	11
2023 Q4	$292K	Buy	+8,984	New	+$292K	0.28%	28